GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elekta AB (OSTO:EKTA B) » Definitions » Debt-to-EBITDA

Elekta AB (OSTO:EKTA B) Debt-to-EBITDA : 2.10 (As of Jan. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Elekta AB Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Elekta AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was kr341 Mil. Elekta AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was kr6,801 Mil. Elekta AB's annualized EBITDA for the quarter that ended in Jan. 2024 was kr3,400 Mil. Elekta AB's annualized Debt-to-EBITDA for the quarter that ended in Jan. 2024 was 2.10.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Elekta AB's Debt-to-EBITDA or its related term are showing as below:

OSTO:EKTA B' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.7   Med: 2.4   Max: 4.66
Current: 2.28

During the past 13 years, the highest Debt-to-EBITDA Ratio of Elekta AB was 4.66. The lowest was 1.70. And the median was 2.40.

OSTO:EKTA B's Debt-to-EBITDA is ranked worse than
63.78% of 439 companies
in the Medical Devices & Instruments industry
Industry Median: 1.26 vs OSTO:EKTA B: 2.28

Elekta AB Debt-to-EBITDA Historical Data

The historical data trend for Elekta AB's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elekta AB Debt-to-EBITDA Chart

Elekta AB Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.70 3.18 2.03 2.12 2.68

Elekta AB Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.92 2.38 2.33 2.00 2.10

Competitive Comparison of Elekta AB's Debt-to-EBITDA

For the Medical Instruments & Supplies subindustry, Elekta AB's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elekta AB's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Elekta AB's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Elekta AB's Debt-to-EBITDA falls into.



Elekta AB Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Elekta AB's Debt-to-EBITDA for the fiscal year that ended in Apr. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(250 + 6418) / 2486
=2.68

Elekta AB's annualized Debt-to-EBITDA for the quarter that ended in Jan. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(341 + 6801) / 3400
=2.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jan. 2024) EBITDA data.


Elekta AB  (OSTO:EKTA B) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Elekta AB Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Elekta AB's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Elekta AB (OSTO:EKTA B) Business Description

Address
Kungstensgatan 18, Box 7593, Stockholm, SWE, SE-103 93
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company's installed base of more than 5,000 linear accelerators, GammaKnife and Unity platforms, and software is used in more than 6,000 hospitals globally. The company's sales are evenly distributed across geographies, with North and South America accounting for 31%; Europe, the Middle East, and Africa accounting for 35%; and Asia-Pacific contributing the remainder.

Elekta AB (OSTO:EKTA B) Headlines

No Headlines